• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    52 Biggest Movers From Yesterday

    2/15/22 4:32:34 AM ET
    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Computer Software: Prepackaged Software
    Technology
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $AEYE alert in real time by email

    Gainers

    • BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60 per share in an all-cash transaction, corresponding to an equity value of approximately $604 million.
    • Knightscope, Inc. (NASDAQ:KSCP) climbed 32.9% to settle at $8.40 after the company announced a partnership with Allied Universal to provide autonomous security robots.
    • China Online Education Group (NYSE:COE) gained 27.7% to close at $2.03.
    • Alpine 4 Holdings, Inc. (NASDAQ:ALPP) climbed 22.3% to settle at $1.81. Alpine 4’s subsidiary Vayu Aerospace recently incorporated solid-state batteries into its autonomous G1 Drone.
    • Cornerstone Building Brands, Inc. (NYSE:CNR) surged 22% to close at $22.44 as private equity firm CD&R offered to acquire all outstanding shares it does not already own of Cornerstone Building Brands for $24.65 per share in cash.
    • Kelly Services, Inc. (NASDAQ:KELYA) climbed 20.9% to close at $20.86 after the company reported Q4 earnings results.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) jumped 19.2% to settle at $2.67.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) surged 17.6% to close at $3.01.
    • Team, Inc. (NYSE:TISI) gained 16.6% to close at $0.8747. Team revealed a series of transactions in its effort to refinance capital structure.
    • Astrea Acquisition Corp. (NASDAQ:ASAX) gained 16.5% to close at $9.75 after the company, HotelPlanner and Reservations.com mutually agreed to terminate their business combination agreement.
    • Cadiz Inc. (NASDAQ:CDZI) surged 15.8% to close at $2.20.
    • Battalion Oil Corporation (NYSE:BATL) gained 14.9% to close at $18.08.
    • Collegium Pharmaceutical, Inc. (NASDAQ:COLL) jumped 13.1% to settle at $19.90 after the company announced it will acquire BioDelivery Sciences.
    • Zurn Water Solutions Corporation (NYSE:ZWS) gained 12.1% to close at $33.40 after the company announced a merger with Elkay Manufacturing.
    • UserTesting, Inc. (NYSE:USER) climbed 11.5% to close at $9.60. UserTesting is expected to announce Q4 financial results on February 28, 2022.
    • Ebix, Inc. (NASDAQ:EBIX) gained 11.4% to settle at $31.93.
    • Freshworks Inc. (NASDAQ:FRSH) climbed 10.9% to close at $20.41. Freshworks recently reported Q4 earnings results.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) gained 9.1% to settle at $0.6130.
    • Excellon Resources Inc. (NYSE:EXN) gained 8.9% to settle at $0.7210.
    • Reliance Global Group, Inc. (NASDAQ:RELI) rose 8.9% to close at $6.37.
    • VTEX (NYSE:VTEX) gained 7.9% to close at $8.18. Credit Suisse initiated coverage on Vtex with a Neutral rating and announced a price target of $10.
    • DiDi Global Inc. (NYSE:DIDI) gained 7.3% to settle at $4.28. Bernstein initiated coverage of DiDi Global with an Outperform rating and $6.20 price target, implying an upside of 55.4%.

    Also check out this: Insiders Buying These 4 Penny Stocks

    Losers

    • Dave Inc. (NASDAQ:DAVE) shares tumbled 36.9% to close at $5.88 on Monday. Dave recently appointed Michael Pope to Board of Directors.
    • RumbleON, Inc. (NASDAQ:RMBL) fell 30.2% to close at $26.86 as the company disclosed senior management changes. The company’s President Peter Levy will succeed Mark Tkach as COO.
    • Gravity Co., Ltd. (NASDAQ:GRVY) fell 26.5% to settle at $45.44. Gravity reported prelim FY21 consolidated revenue of KRW414 billion.
    • Bright Health Group, Inc. (NYSE:BHG) fell 22.5% to settle at $2.96. Bright Health Group is expected to report Q4 financial results on Wednesday, March 2, 2022.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) dropped 22.1% to close at $5.41.
    • LAVA Therapeutics N.V. (NASDAQ:LVTX) fell 21.1% to settle at $4.55. LAVA Therapeutics recently announced dosing of the first patient in its Phase 1/2a clinical trial of LAVA-1207 in patients with metastatic castration-resistant prostate cancer.
    • Mullen Automotive, Inc. (NASDAQ:MULN) declined 20.2% to close at $1.07.
    • Fast Radius, Inc. (NASDAQ:FSRD) dropped 19.1% to settle at $3.01.
    • Agrify Corporation (NASDAQ:AGFY) fell 18.7% to settle at $6.92.
    • Sea Limited (NYSE:SE) dropped 18.4% to close at $129.17. JP Morgan maintained Sea with an Overweight and lowered the price target from $420 to $250.
    • Momentus Inc. (NASDAQ:MNTS) fell 18% to settle at $3.00.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) dipped 17.7% to close at $10.72.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) fell 16.5% to settle at $6.60. Allarity Therapeutics and Oncoheroes Biosciences recently entered into licensing agreements for Allarity's dovitinib and stenoparib for further clinical development in pediatric cancers.
    • LumiraDx Limited (NASDAQ:LMDX) fell 15.9% to close at $7.65.
    • InterCure Ltd. (NASDAQ:INCR) shares fell 15.2% to close at $6.95 after jumping 22% on Friday. Intercure recently reported preliminary Q4 revenue.
    • iPower Inc. (NASDAQ:IPW) declined 14.4% to settle at $1.63. The company reported better-than-expected Q2 EPS and sales results after the closing bell on Monday.
    • AudioEye, Inc. (NASDAQ:AEYE) fell 14% to close at $5.30.
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 13.7% to close at $3.22.
    • T Stamp Inc. (NASDAQ:IDAI) fell 13.1% to settle at $4.05.
    • Senseonics Holdings, Inc. (NYSE:SENS) fell 12.8% to close at $2.11 on Monday. The FDA recently approved the company’s Eversense E3 Continuous Glucose Monitoring (CGM) System.
    • FingerMotion, Inc. (NASDAQ:FNGR) dropped 12.5% to close at $3.00.
    • Moderna, Inc. (NASDAQ:MRNA) dropped 11.7% to close at $142.47. The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from Pfizer / BioNTech, and Moderna.
    • Novavax, Inc. (NASDAQ:NVAX) fell 11.4% to close at $80.11. Novavax recently said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged 12 to 17 years.
    • IceCure Medical Ltd (NASDAQ:ICCM) shares dipped 10.7% to close at $2.60. IceCure Medical recently said it sees preliminary FY21 revenues of $4.1 million, up from $3.9 million year-over-year.
    • Modular Medical, Inc. (NASDAQ:MODD) fell 9.6% to close at $3.85. Modular Medical shares jumped around 15% on Friday following its recent uplisting to the Nasdaq Capital Market on Thursday.
    • BRC Inc. (NYSE:BRCC) fell 7.9% to close at $15.00.
    • Standard Lithium Ltd. (NYSE:SLI) fell 7.8% to settle at $5.93. Hindenburg Research recently issued a bearish report on Standard Lithium.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares fell 7.5% to close at $3.82. HeartCore Enterprises recently priced its IPO at $5 per share.
    • CF Industries Holdings, Inc. (NYSE:CF) fell 6.5% to close at $71.46.
    • Leafly Holdings, Inc. (NASDAQ:LFLY) fell 5.9% to close at $6.69.


    Also check out this: Discover Financial Services And 3 Other Stocks Sold By Insiders

    Get the next $AEYE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEYE
    $AGFY
    $ALLR
    $ALPP

    CompanyDatePrice TargetRatingAnalyst
    CF Industries Holdings Inc.
    $CF
    2/4/2026$72.00Neutral → Sell
    Rothschild & Co Redburn
    Freshworks Inc.
    $FRSH
    2/3/2026$12.00Overweight → Neutral
    Piper Sandler
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    VTEX
    $VTEX
    1/15/2026$4.00Buy → Neutral
    UBS
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    Zurn Elkay Water Solutions Corporation
    $ZWS
    1/5/2026$49.00Sector Perform
    RBC Capital Mkts
    Freshworks Inc.
    $FRSH
    12/17/2025Neutral
    BTIG Research
    More analyst ratings

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Large owner Corre Partners Management, Llc bought $44,675 worth of shares (2,996 units at $14.91) (SEC Form 4)

    4 - TEAM INC (0000318833) (Issuer)

    12/8/25 7:31:50 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jahnke Timothy J sold $902,876 worth of shares (17,900 units at $50.44), decreasing direct ownership by 6% to 288,964 units (SEC Form 4)

    4 - Zurn Elkay Water Solutions Corp (0001439288) (Issuer)

    2/6/26 5:55:41 PM ET
    $ZWS
    Industrial Machinery/Components
    Industrials

    Chief Administrative Officer Peterson Mark W sold $1,191,606 worth of shares (23,183 units at $51.40), decreasing direct ownership by 7% to 295,378 units (SEC Form 4)

    4 - Zurn Elkay Water Solutions Corp (0001439288) (Issuer)

    2/6/26 5:55:35 PM ET
    $ZWS
    Industrial Machinery/Components
    Industrials

    Chief Integr Cust Growth Offcr Yamamoto Mika was granted 90,140 shares, increasing direct ownership by 8% to 1,181,561 units (SEC Form 4)

    4 - Freshworks Inc. (0001544522) (Issuer)

    2/5/26 5:13:14 PM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    SEC Filings

    View All

    SEC Form 424B5 filed by Momentus Inc.

    424B5 - Momentus Inc. (0001781162) (Filer)

    2/6/26 4:53:27 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    2/6/26 1:10:23 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form EFFECT filed by Momentus Inc.

    EFFECT - Momentus Inc. (0001781162) (Filer)

    2/6/26 12:15:14 AM ET
    $MNTS
    Military/Government/Technical
    Industrials

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

    VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away from broad chemotherapy and toward precision biologics like mRNA and oncolytic viruses. The FDA is actively accelerating this cycle, having granted multiple breakthrough designations in January 2026 alone for platforms that demonstrate genuine survival durability[2]. This structural realignment positions Oncolytics Biotech Inc. (NASDAQ:ONCY), Moderna (NASDAQ:MRNA), Immunome (NASDAQ:IMNM), Autolus Therapeutics (NASDAQ:AUTL), and Prelude Therapeutics (NASDAQ:PRLD) within the emerging biological innovation c

    2/5/26 9:26:03 AM ET
    $AUTL
    $IMNM
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Knightscope Retains Lake Street to Support Growth Through Acquisitions

    Knightscope, Inc. (NASDAQ:KSCP), a security technology company building the Nation's first Autonomous Security Force, today announced that it has retained Lake Street Capital Markets, a full-service investment bank, as its exclusive buy-side financial advisor to support the Company's growth strategy through acquisitions of complementary businesses, technologies, and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205409078/en/ This engagement reflects Knightscope's ongoing efforts to strengthen its market position and accelerate growth through selective, disciplined acquisitions aligned with its long-term strateg

    2/5/26 9:00:00 AM ET
    $KSCP
    Telecommunications Equipment
    Telecommunications

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CF Industries downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded CF Industries from Neutral to Sell and set a new price target of $72.00

    2/4/26 8:27:16 AM ET
    $CF
    Agricultural Chemicals
    Industrials

    Freshworks downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Freshworks from Overweight to Neutral and set a new price target of $12.00

    2/3/26 6:53:05 AM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    Maxim Group initiated coverage on Cadiz with a new price target

    Maxim Group initiated coverage of Cadiz with a rating of Buy and set a new price target of $10.00

    2/2/26 7:47:52 AM ET
    $CDZI
    Water Supply
    Utilities

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Leadership Updates

    Live Leadership Updates

    View All

    Dave O'Hara Joins Cadiz Board of Directors

    Former Microsoft Commercial CFO brings decades of experience in corporate finance and commercial strategy LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Cadiz, Inc. (NASDAQ:CDZI, the ", Company", )) announced today that Mr. Dave O'Hara, a senior finance executive with extensive experience in corporate finance, commercial strategy and large-scale growth initiatives, has joined the Company's Board of Directors. Mr. O'Hara spent more than 20 years at Microsoft in senior executive leadership roles, most recently serving as Executive Vice President and Chief Financial Officer of Microso

    2/4/26 9:46:00 AM ET
    $CDZI
    Water Supply
    Utilities

    Team, Inc. Announces Planned Leadership Transition and Names Gary Hill as Chief Executive Officer

    SUGAR LAND, Texas, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) ("TEAM" or the "Company"), a leading provider of specialty industrial services offering a full suite of mechanical, heat-treating, and inspection services around the world, today announced that Keith Tucker will retire from Team after over 20 years of service. In conjunction with this planned leadership transition, TEAM's Board of Directors has appointed Gary Hill as the Company's Chief Executive Officer effective February 1, 2026 to lead the Company in its continued focus on driving accelerated growth and margin improvements. The Company also reaffirms its previously issued 2025 outlook. "On behalf of the Board o

    1/26/26 5:00:00 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    $AEYE
    $AGFY
    $ALLR
    $ALPP
    Financials

    Live finance-specific insights

    View All

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Kelly Announces Fourth-Quarter and Full-Year 2025 Conference Call

    TROY, Mich., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter and full-year earnings before the market opens on Thursday, February 12, 2026. In conjunction with its earnings release, Kelly will publish a financial presentation and host a live webcast of a conference call with financial analysts at 9 a.m. ET on February 12 to review the results from the quarter and answer questions. The presentation and a link to the live webcast will be accessible through the Company's public website on the Investor Relations page under Events & Presentations. The webcast will be recorded, and a replay will be available within o

    2/5/26 7:30:00 AM ET
    $KELYA
    $KELYB
    Professional Services
    Consumer Discretionary

    Zurn Elkay Water Solutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Investor call scheduled for Wednesday, February 4, 2026 at 8:30 a.m. Eastern Time Zurn Elkay Water Solutions Corporation (NYSE:ZWS) Fourth Quarter Highlights Net sales in the quarter were $407 million compared with $371 million in last year's December quarter (+10% core sales(1)). Net income from continuing operations was $42 million (diluted EPS from continuing operations of $0.24) compared with net income from continuing operations of $36 million (diluted EPS from continuing operations of $0.21) in the year-ago quarter. Adjusted EPS(1) was $0.36 compared with $0.32 in the year-ago quarter. Adjusted EBITDA(1) was $104 million (25.6% of net sales) compared with $91 million (

    2/3/26 4:05:00 PM ET
    $ZWS
    Industrial Machinery/Components
    Industrials